Grepafloxacin is a broad-spectrum fluoroquinolone antibacterial agent that was historically developed to treat a variety of bacterial infections. As a member of the fluoroquinolone class, it functions… Read more
Grepafloxacin is a broad-spectrum fluoroquinolone antibacterial agent that was historically developed to treat a variety of bacterial infections. As a member of the fluoroquinolone class, it functions by inhibiting essential bacterial enzymes to halt pathogen replication. This category features high-quality reference standards of the Grepafloxacin active pharmaceutical ingredient, alongside related impurities, stereoisomers, and stable isotope-labelled compounds essential for pharmaceutical analysis. Analytical laboratories utilize these materials for impurity profiling, ensuring accurate identification and quantification of degradation products or synthesis by-products. These reference materials support rigorous method development, analytical method validation, and routine quality control processes, allowing researchers to maintain strict compliance with regulatory standards when characterizing Grepafloxacin and its associated substances in complex matrices.